Ipsilateral silent period: A marker of callosal conduction abnormality in early relapsing-remitting multiple sclerosis?

被引:31
|
作者
Jung, Patrick
Beyerle, Astrid
Hurnpich, Marek
Neumann-Haefelin, Tobias
Lanfermann, Heinrich
Ziemann, Ulf
机构
[1] Univ Frankfurt, Dept Neurol, D-60528 Frankfurt, Germany
[2] Univ Frankfurt, Inst Neuroradiol, D-6000 Frankfurt, Germany
关键词
ipsilateral silent period; central motor conduction time; transcranial magnetic stimulation; corpus callosuni; relapsing-remitting multiple sclerosis;
D O I
10.1016/j.jns.2006.08.008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: The corpus callosum (CC) is commonly affected in multiple sclerosis (MS). The ipsilateral silent period (iSP) is a putative electrophysiological marker of callosal demyelination. The purpose of this study was to re-assess, under recently established optimised protocol conditions [Jung P., Ziemann U. Differences of the ipsilateral silent period in small hand muscles. Muscle Nerve in press.], its diagnostic sensitivity in MS, about which conflicting results were reported in previous studies. Methods: ISP measurements (onset, duration, and depth) were obtained in the abductor pollicis brevis (APB) muscle of either hand in 49 patients with early relapsing-remitting MS (RRMS) (mean EDSS, 1.3). Standard central motor conduction times to the APB (CMCTAPB) and tibial anterior muscles (CMCTTA), and magnetic resonance images (MRI) were also obtained. Results: ISP measurements showed a similar diagnostic sensitivity (28.6%) as CMCTAPB (24.5%), while diagnostic sensitivities of CMCTTA (69.4%) and MRI of the CC (78.6%) were much higher. Prolongation of iSP duration was the most sensitive single iSP measure. ISP prolongation occurred more frequently when CMCTAPB to the same hand was also prolonged (40.0% vs. 8.4%, p < 0.000 1). The correlation between iSP duration and CMCTAPB was significant (Pearson's r=0.24, p < 0.02), suggesting that iSP duration can be contaminated by demyclination of the contralateral corticospinal tract. ISP duration did not correlate with MRI abnon-nalities of the CC. Conclusions: ISP measures are neither a sensitive nor a specific marker of callosal conduction abnormality in early RRMS. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:133 / 139
页数:7
相关论文
共 50 条
  • [41] Actual adherence to dimethyl fumarate in patients with relapsing-remitting multiple sclerosis
    de Sa, Joao
    Ferreira, Joao
    Macedo, Ana M.
    REVISTA DE NEUROLOGIA, 2023, 76 : S1 - S6
  • [42] Alemtuzumab improves contrast sensitivity in patients with relapsing-remitting multiple sclerosis
    Graves, Jennifer
    Galetta, Steven L.
    Palmer, Jeffrey
    Margolin, David H.
    Rizzo, Marco
    Bilbruck, John
    Balcer, Laura J.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (10) : 1302 - 1309
  • [43] EXTENDING THERAPEUTIC POSSIBILITIES IN RELAPSING-REMITTING MULTIPLE SCLEROSIS: DIMETHYL FUMARATE
    Matolcsi Judit
    Rozsa Csilla
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2015, 68 (1-2): : 7 - 14
  • [44] Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study
    Jai Perumal
    Roumen Balabanov
    Ray Su
    Roger Chang
    Laura Balcer
    Steven Galetta
    Denise I. Campagnolo
    Robin Avila
    Lily Lee
    Danette Rutledge
    Robert J. Fox
    Advances in Therapy, 2021, 38 : 3724 - 3742
  • [45] Long-term prognosis communication preferences in early-stage relapsing-remitting multiple sclerosis
    Castillo-Trivino, Tamara
    Gomez-Ballesteros, Rocio
    Borges, Monica
    Martin-Martinez, Jesus
    Sotoca, Javier
    Alonso, Ana
    Caminero, Ana B.
    Borrega, Laura
    Sanchez-Menoyo, Jose L.
    Barrero-Hernandez, Francisco J.
    Calles, Carmen
    Brieva, Luis
    Blasco-Quilez, Maria R.
    Garcia-Soto, Julio Dotor
    del Campo-Amigo, Maria
    Navarro-Canto, Laura
    Aguera, Eduardo
    Garces-Redondo, Moises
    Carmona, Olga
    Gabaldon-Torres, Laura
    Forero, Lucia
    Hervas, Mariona
    Maurino, Jorge
    de la Maza, Susana Sainz
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 64
  • [46] Cortical Excitability and Interhemispheric Connectivity in Early Relapsing-Remitting Multiple Sclerosis Studied With TMS-EEG
    Zipser, Carl M.
    Premoli, Isabella
    Belardinelli, Paolo
    Castellanos, Nazareth
    Rivolta, Davide
    Heidegger, Tonio
    Mueller-Dahlhaus, Florian
    Ziemann, Ulf
    FRONTIERS IN NEUROSCIENCE, 2018, 12
  • [47] Cognitive functions and disability progression in relapsing-remitting multiple sclerosis: A longitudinal study
    Heled, Eyal
    Aloni, Roy
    Achiron, Anat
    APPLIED NEUROPSYCHOLOGY-ADULT, 2021, 28 (02) : 210 - 219
  • [48] Comparison of efficacy and safety of oral agents for the treatment of relapsing-remitting multiple sclerosis
    Guarnera, Cristina
    Bramanti, Placido
    Mazzon, Emanuela
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 2193 - 2207
  • [49] Negative interpretation of ambiguous bodily information by patients with relapsing-remitting multiple sclerosis
    Hosseinchi, Parham
    Ghalibaf, Erfan
    Dehghani, Ali
    Khatibi, Ali
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 62
  • [50] Assessment of new application system in Portuguese patients with relapsing-remitting multiple sclerosis
    de Sa, J.
    Urbano, G.
    Reis, L.
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (09) : 2237 - 2242